Boston Scientific takes over Cook&#39;s share of drug rights
445058
Bloomington (Star report) --Boston Scientific Corp. has obtained exclusive rights to sell the most popular coating on heart stents, taking over the share previously held by Cook Inc.
482241
The drugmaker bumps into the FDA as it pushes to do more testing of Entereg.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
35589
The Food and Drug Administration has signed off on the safety of a portion of five (m) million doses that are available from plants in Canada and Germany.
188313
A contentious legal fight between Boston Scientific Corp. and a California subsidiary it bought in 2004 took a sharp twist this week when lawyers asked a judge to consider undoing the deal.
117450
WASHINGTON -- Federal drug regulators are using a &quot;lighter touch&quot; in their efforts to stop a growing number of cities and states from importing prescription drugs from Canada, and the City of Boston is taking advantage of that new posture.
355967
OXiGENE reaches a deal with FDA on its lead compound.
242397
Boston Scientific Corp. said yesterday it has won back the market share that its flagship cardiac stent system held before three safety recalls reduced doctors' orders of the product.
586348
As part of a federal inquiry into drug and medical-device marketing, Boston Scientific Corp. was asked by Congress last week to submit to investigators internal documents, marketing plans, and clinical data related to its top-selling product, the Taxus drug-coated stent.
325151
The U.S. House of Representatives voted on Wednesday to give the Food and Drug Administration more power over drugmakers as part of an effort to better protect the public from dangerous medicines.
71368
Boston Scientific Corp. is putting its efforts to reach chronic pain sufferers on the fast track. The medical-device maker said it will sponsor a Formula race car team as part of a Race Against Pain marketing program.
279854
erck &amp; Company has obtained rights to license an experimental drug to treat obesity that has generated scientific interest because it is based on a hormone used by the body to signal that it has eaten enough.
566909
The FDA decides to debate the company's lead drug.
200231
A Texas jury has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist and has awarded the inventor $431 million in damages, Boston Scientific said.
624210
Boston Scientific Corp. chief executive James R. Tobin is putting his money where his mouth is.
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.